Sponsor:
AstraZeneca
Code:
NCT05166889
Conditions
Chronic Obstructive Pulmonary Disease (COPD)
Eligibility Criteria
Sex: All
Age: 40 - 70+
Healthy Volunteers: Not accepted
Interventions
Tozorakimab
Tozorakimab
Placebo
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations